Characterizing Chronic Cutaneous Immune-Related Adverse Events Following Immune Checkpoint Inhibitors

Kylie A. Fletcher; Rachel S. Goodman; Aleigha Lawless; Rachel Woodford; Faisal Fa’ak; Asha Tipirneni; J. Randall Patrinely; Hui Ling Yeoh; Suthee Rapisuwon; Andrew Haydon; Iman Osman; Janice M. Mehnert; Georgina V. Long; Ryan J. Sullivan; Matteo S. Carlino; Alexander M. Menzies; Anna K. Dewan; Douglas B. Johnson

Journal Article

Characterizing Chronic Cutaneous Immune-Related Adverse Events Following Immune Checkpoint Inhibitors

JAMA Dermatology (2025) 161(5) 555-557

DOI: 10.1001/jamadermatol.2025.0025

1Citations

3Readers

Get full text

Cite

CITATION STYLE

APA

Fletcher, K. A., Goodman, R. S., Lawless, A., Woodford, R., Fa’ak, F., Tipirneni, A., … Johnson, D. B. (2025). Characterizing Chronic Cutaneous Immune-Related Adverse Events Following Immune Checkpoint Inhibitors. JAMA Dermatology, 161(5), 555–557. https://doi.org/10.1001/jamadermatol.2025.0025

Characterizing Chronic Cutaneous Immune-Related Adverse Events Following Immune Checkpoint Inhibitors

Cite

Register to see more suggestions